Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 428 | 2,081 | 149 | 2,668 | 1,608 |
| Cost of Goods | 429 | 1,209 | 40 | 1,255 | 1,039 |
| Gross Profit | -1 | 872 | 109 | 1,413 | 568 |
| Operating Expenses | 2,653 | 4,795 | 3,467 | 4,777 | 5,452 |
| Operating Income | -2,654 | -3,923 | -3,357 | -3,364 | -4,884 |
| Interest Expense | 243 | 545 | 1,215 | 822 | 416 |
| Other Income | 67 | -3 | 10 | 362 | 450 |
| Pre-tax Income | -2,829 | -4,471 | -4,562 | -3,824 | -4,850 |
| Income Tax | -108 | -1,310 | N/A | N/A | N/A |
| Net Income Continuous | -2,721 | -3,161 | -4,562 | -3,824 | -4,850 |
| Net Income Discontinuous | 0 | 9,327 | -708 | N/A | N/A |
| Minority Interests | 0 | -68 | 236 | -66 | 245 |
| Net Income | $-2,721 | $6,098 | $-5,034 | $-3,890 | $-4,605 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.04 | -0.03 | -0.04 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 |
| EPS Basic Discontinuous Ops | 0.00 | 0.07 | -0.01 | N/A | N/A |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.04 | -0.03 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.06 | -0.01 | N/A | N/A |
| EBITDA(a) | $-2,424 | $-3,707 | $-3,109 | $-2,738 | $-4,246 |